MedPath

MediWound

MediWound logo
🇮🇱Israel
Ownership
Public
Established
2001-01-01
Employees
100
Market Cap
$186.6M
Website
http://www.mediwound.com
Introduction

MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.

© Copyright 2025. All Rights Reserved by MedPath